Clinical, Immunological, And Genetic Characterization Of Colombian Patients With Cutaneous Recalcitrant Warts

Autores/as

DOI:

https://doi.org/10.17533/udea.iatreia.350284

Palabras clave:

Verruga, Verruca, Verrucae, Warts, Resistant, WES, HPV

Resumen

Inborn errors of innate and intrinsic immunity are monogenic diseases that result in a predisposition to a whole spectrum of infectious diseases, including viral infections. Cutaneous warts caused by Human Papillomavirus (HPV) infection have a ~10% incidence in the general population. These lesions are relatively common, and most warts revert spontaneously. However, in otherwise healthy individuals, these warts persist for > 2 years without response to conventional therapy (cryotherapy, salicylic acid, or bleomycin), and they are called recalcitrant warts (RW). Host defense against HPV relies on intact and functioning cellular immunity including T cell, natural killer cell cytotoxicity, and intrinsic immunity. Therefore, in patients in whom warts are recalcitrant, concern for immune defects is raised.

|Resumen
= 754 veces | PDF
= 84 veces|

Descargas

Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Julián Rojas, Universidad de Antioquia, Medellín, Colombia

Corporación Académica Ciencias Básicas Biomédicas- Grupo de Inmunodeficiencias Primarias, Universidad de Antioquia, Medellín, Colombia. 

Margarita María Velásquez, Universidad de Antioquia, Medellín, Colombia

Unidad de Dermatología, Centro de investigaciones Dermatológicas, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.

Emmanuelle Jouanguy, Paris Descartes University, Paris, France

Human Genetics of Infectious Diseases INSERM, Paris Descartes University, Paris, France.

 

Juan Álvaro López, Universidad de Antioquia, Medellín, Colombia

Grupo de Inmunodeficiencias Primarias. Escuela de Microbiología, Universidad de Antioquia, Medellín, Colombia.

 

José Luisa Franco, Universidad de Antioquia, Medellín, Colombia

Grupo de Inmunodeficiencias Primarias, Universidad de Antioquia, Medellín, Colombia.

Andrés Augusto Arias, Universidad de Antioquia, Medellín, Colombia

Grupo de Inmunodeficiencias Primarias, Escuela de Microbiología, Universidad de Antioquia, Medellín, Colombia.

Citas

(1) Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40(1):24-64.

(2) Leung L. Recalcitrant nongenital warts. Australian Family Physician. 2011;40(1-2):40-2.

(3) Massing AM, Epstein WL. Natural history of warts. A two-year study. Arch Dermatol. 1963;87:306-10.

(4) Scheurer ME, Tortolero-Luna G, Adler-Storthz K. Human papillomavirus infection: biology, epidemiology, and prevention. Int J Gynecol Cancer. 2005;15(5):727- 46.

(5) Stanley M. Immune responses to human papillomavirus. Vaccine. 2006;24 Suppl 1:S16-22.

(6) Cubie HA. Diseases associated with human papillomavirus infection. Virology. 2013;445(1-2):21-34.

(7) Leiding JW, Holland SM. Warts and all: human papillomavirus in primary immunodeficiencies. J Allergy Clin Immunol. 2012;130(5):1030-48.

(8) Kalinska-Bienias A, Kowalewski C, Majewski S. The EVER genes - the genetic etiology of carcinogenesis in epidermodysplasia verruciformis and a possible role in non-epidermodysplasia verruciformis patients. Postepy Dermat Correo: cristian.anacona@ udea.edu.co ol Alergol. 2016;33(2):75-80.

(9) de Jong SJ, Créquer A, Matos I, Hum D, Gunasekharan V, Lorenzo L, et al. The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses. J Exp Med. 2018;215(9):2289- 310.

Descargas

Publicado

31-08-2022

Cómo citar

1.
Rojas J, Velásquez MM, Jouanguy E, López J Álvaro, Franco JL, Arias AA. Clinical, Immunological, And Genetic Characterization Of Colombian Patients With Cutaneous Recalcitrant Warts. Iatreia [Internet]. 31 de agosto de 2022 [citado 2 de febrero de 2025];35(1-S):S26-S27. Disponible en: https://revistas.udea.edu.co/index.php/iatreia/article/view/350284

Número

Sección

Suplemento

Artículos más leídos del mismo autor/a